Kura Oncology, Inc. (NASDAQ:KURA) Q1 2022 Earnings Conference Call May 4, 2022 4:30 PM ET Company Participants Troy Wilson – Chairman and Chief Executive Officer Tom Doyle – Senior Vice President, Finance and Accounting Pete De Spain – Senior Vice President, Investor Relations and Corporate Communications Conference Call Participants Jonathan Chang – SVB Securities Peter Lawson – Barclays Corporate & Investment Bank Jonathan Ofertiago – Credit Suisse Roger Song – Jefferies Reni Benjamin – JMP Securities Eva ...

DEVELOPING PRECISION MEDICINES FOR THE TREATMENT OF CANCER ......... Corporate Presentation – February 2022 Forward-Looking Statements This presentation contains forward-looking statements. Such statements include, but are not limited to, statements regarding our research, preclinical and clinical development activities, plans and projected timelines for ziftomenib, tipifarnib and KO-2806, plans regarding regulatory filings, our expectations regarding the relative benefits of our product candidates versus c ...

Kura Oncology, Inc. (NASDAQ:KURA) Q4 2021 Earnings Conference Call February 24, 2022 4:30 PM ET Company Participants Troy Wilson – Chairman, Chief Executive Officer & President Tom Doyle – Senior Vice President of Finance and Accounting Pete De Spain – Vice President, Investor Relations & Corporate Communications Conference Call Participants Jonathan Chang – SVB Leerink Peter Lawson – Barclays Bank Tiago Fauth – Crédit Suisse Ren Benjamin – JMP Securities Roger Song – Jefferies Phil Nadeau – Cowen and Compa ...

Kura Oncology, Inc. (NASDAQ:KURA) Q3 2021 Earnings Conference Call November 4, 2021 4:30 PM ET Company Participants Pete De Spain - VP, IR & Corporate Communications Troy Wilson - Chairman, CEO & President Marc Grasso - CFO & Chief Business Officer Stephen Dale - Chief Medical Officer Conference Call Participants Jonathan Chang - SVB Leerink Tiago Fauth - Crédit Suisse Peter Lawson - Barclays Bank Ren Benjamin - JMP Securities Joe Pantginis - H.C. Wainwright Eva Previtera - Cowen Operator Good day, and welc ...

DEVELOPING PRECISION MEDICINES FOR THE TREATMENT OF CANCER 0 0 Corporate Presentation – September 2021 Forward-Looking Statements This presentation contains forward-looking statements. Such statements include, but are not limited to, statements regarding our research, preclinical and clinical development activities, plans and projected timelines for tipifarnib, KO-539 and KO-2806, plans regarding regulatory filings, our expectations regarding the relative benefits of our product candidates versus competitiv ...

Kura Oncology, Inc. (NASDAQ:KURA) Q2 2021 Earnings Conference Call August 5, 2021 4:30 PM ET Company Participants Pete De Spain - VP, IR & Corporate Communications Troy Wilson - Chairman, CEO & President Marc Grasso - CFO & Chief Business Officer Conference Call Participants Jonathan Chang - SVB Leerink Peter Lawson - Barclays Bank Tiago Fauth - Crédit Suisse Reni Benjamin - JMP Securities Philip Nadeau - Cowen and Company Operator Good day, and thank you for standing by, and welcome to the Second Quarter 2 ...

Kura Oncology, Inc. (NASDAQ:KURA) Q1 2021 Earnings Conference Call May 6, 2021 4:30 PM ET Company Participants Pete Spain - Vice President, Investor Relations and Corporate Communications Troy Wilson - President and Chief Executive Officer Marc Grasso - Chief Financial Officer and Chief Business Officer Francis Burrows - Vice President, Translational Research Conference Call Participants Wei Chang - SVB Leerink LLC Peter Lawson - Barclays Bank PLC Reni Benjamin - JMP Securities Joseph Pantginis - H.C. Wainw ...

DEVELOPING PRECISION MEDICINES FOR THE TREATMENT OF CANCER ......... Corporate Presentation – May 2021 Forward-Looking Statements This presentation contains forward-looking statements. Such statements include, but are not limited to, statements regarding our research, preclinical and clinical development activities, plans and projected timelines for tipifarnib and KO-539, plans regarding regulatory filings, our expectations regarding the relative benefits of our product candidates versus competitive therapi ...

Kura Oncology, Inc. (NASDAQ:KURA) Q4 2020 Results Earnings Conference Call February 24, 2021 8:00 AM ET Company Participants Pete De Spain - Investor Relations Troy Wilson - President and Chief Executive Officer Marc Grasso - Chief Financial Officer Stephen Dale - Chief Medical Officer Jim Basta - Chief Legal Officer Kirsten Flowers - Chief Commercial Officer Kathy Ford - Chief Operating Officer Conference Call Participants Jonathan Chang - SVB Leerink Brian Marty Auster - Credit Suisse Peter Lawson - Barcl ...

DEVELOPING PRECISION MEDICINES FOR THE TREATMENT OF CANCER J.P. Morgan Healthcare Conference – January 11-14, 2021 Forward-Looking Statements This presentation contains forward-looking statements. Such statements include, but are not limited to, statements regarding our research, preclinical and clinical development activities, plans and projected timelines for tipifarnib and KO-539, plans regarding regulatory filings, our expectations regarding the relative benefits of our product candidates versus competi ...